STUB1 and obesity disorder: Additionally, the drug has been shown to facilitate proliferation and migration of breast cancer cells, suggesting potential crosstalk between cardiovascular therapeutics and oncogenic pathways, while raising concerns about unintended consequences in individuals with both CHIP and obesity [110].